Image

A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

Testing RO7434656 for IgA Nephropathy progression risk.

Recruiting
18 years and older
All
Phase 3

This study tests a new treatment called RO7434656 for people with a kidney problem called Immunoglobulin A (IgA) Nephropathy. This condition is when IgA, a protein that helps fight infections, builds up in the kidneys and can lead to kidney damage. The study aims to see if RO7434656 is safe and works well for people whose kidney disease is getting worse despite usual care.

Participants must have kidney damage confirmed by a test called a biopsy, and must have tried certain medications to help protect the kidneys. The study will not accept people who are pregnant or have other serious health issues.

  • The study examines the safety and effectiveness of the new treatment RO7434656.
  • Participants will be closely monitored, and certain medications are not allowed during the study.
  • There are specific eligibility criteria, such as having high levels of protein in urine and not being pregnant.

This study could help improve treatment for people with serious kidney disease, but it requires careful consideration of whether you meet the criteria and are comfortable with the study's rules.

Study details
    Primary IgA Nephropathy

NCT05797610

Hoffmann-La Roche

16 March 2025

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.